DSM to increase price for Akulon® and Novamid® polyamide 6 polymers in the Americas

SINGAPORE, 31-Mar-2016 — /EuropaWire/ — As a result of increasing raw material prices DSM will increase the price for its Akulon® and Novamid® polyamide 6 polymers. DSM will increase prices by $0.05/lb in North and South America. This increase will take effect for all orders shipped on or after 1 April 2016 where contracts allow.

While DSM continues to pursue and implement cost savings initiatives targeted at absorbing the impact of the raw material escalations, this additional increase is necessary to ensure DSM’s sustainable long-term position as leading supplier of engineering plastics.

More information can be found at www.akulon.com and www.novamid.com.

DSM – Bright Science. Brighter Living.™ Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in life sciences and materials sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders simultaneously. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 25,000 employees. The company is listed on Euronext Amsterdam. More information can be found at www.dsm.com.


For more information:
Paula Wolfe
DSM Engineering Plastics
Tel.: 812 435 7539
Fax: 812 435 7702
E-mail: paula.wolfe@dsm.com

Inka Finne
Tel.: +31 164 317 019
Fax: +31 164 317 039
E-mail: ifinne@emg-pr.com

Forward-looking statements
This press release may contain forward-looking statements with respect to DSM’s future (financial) performance and position. Such statements are based on current expectations, estimates and projections of DSM and information currently available to the company. DSM cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. DSM has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is leading.


Comments are closed.